RLBAX
Price
$38.56
Change
-$0.09 (-0.23%)
Updated
Oct 7 closing price
Net Assets
266.1B
TRPBX
Price
$26.27
Change
-$0.09 (-0.34%)
Updated
Oct 7 closing price
Net Assets
2.08B
Interact to see
Advertisement

RLBAX vs TRPBX

Header iconRLBAX vs TRPBX Comparison
Open Charts RLBAX vs TRPBXBanner chart's image
American Funds American Balanced R1
Price$38.56
Change-$0.09 (-0.23%)
VolumeN/A
Net Assets266.1B
T. Rowe Price Spectrum Moderate Allc I
Price$26.27
Change-$0.09 (-0.34%)
VolumeN/A
Net Assets2.08B
RLBAX vs TRPBX Comparison Chart in %
View a ticker or compare two or three
VS
RLBAX vs. TRPBX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLBAX is a Hold and TRPBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBAX has more cash in the bank: 266B vs. TRPBX (2.08B). TRPBX pays higher dividends than RLBAX: TRPBX (2.32) vs RLBAX (1.10). RLBAX was incepted earlier than TRPBX: RLBAX (23 years) vs TRPBX (31 years). RLBAX (1.31) is less costly to investors than TRPBX (0.93). TRPBX (45.00) and RLBAX (44.00) have comparable annual turnover. RLBAX has a lower initial minimum investment than TRPBX: RLBAX (250) vs TRPBX (2500). RLBAX annual gain was more profitable for investors over the last year : 9.12 vs. TRPBX (7.09). RLBAX return over 5 years is better than : 38.04 vs. TRPBX (13.44).
RLBAXTRPBXRLBAX / TRPBX
Total Expense Ratio1.310.75175%
Annual Report Gross Expense Ratio1.310.93141%
Fund Existence23 years31 years-
Gain YTD13.77012.415111%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets266B2.08B12,795%
Annual Yield % from dividends1.102.3247%
Returns for 1 year9.127.09129%
Returns for 3 years47.9835.22136%
Returns for 5 years38.0413.44283%
Returns for 10 years68.7241.53165%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WLY38.330.03
+0.09%
John Wiley & Sons
ROIV16.12-0.14
-0.86%
Roivant Sciences Ltd
PRLD1.44-0.02
-1.37%
Prelude Therapeutics
IVP0.98-0.03
-3.18%
Inspire Veterinary Partners Inc
GRRR19.99-0.68
-3.29%
Gorilla Technology Group